Form 4: Celanese Corp Director Kuehn Adjusts Holdings

Celanese Corp director Christopher J. Kuehn reported a series of transactions involving restricted stock units and phantom stock, reflecting a deferral of compensation.

Summary

• Director Christopher J. Kuehn engaged in transactions on May 9, 2026, and May 11, 2026.
• On May 9, 2026, 3,376 Restricted Stock Units (RSUs) granted on May 9, 2025, vested.
• Instead of receiving shares of common stock, Kuehn deferred receipt and received 3,376 shares of phantom stock under the Company's 2008 Deferred Compensation Plan.
• This transaction is reported as a disposition of 3,376 shares of common stock in exchange for an equal number of phantom stock shares.
• On May 11, 2026, Kuehn received an annual grant of 2,975 restricted stock units.
• These RSUs vest in full one year from the grant date.
• Upon vesting, Kuehn has elected to defer the receipt of common stock, receiving phantom stock instead.
• Phantom stock shares represent the right to receive one share of common stock upon election or termination of service as a director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details routine equity compensation transactions by a director rather than significant strategic or financial events.

Positives

• Director Kuehn received an annual grant of 2,975 restricted stock units, indicating continued equity-based compensation.
• The deferral of compensation through phantom stock aligns with the company's deferred compensation plan, potentially offering tax advantages or long-term incentive alignment for the director.

Negatives

• The disposition of 3,376 shares of common stock, even if exchanged for phantom stock, represents a reduction in direct ownership of common stock at the time of vesting.

Risks

• The value of phantom stock is tied to the company's common stock price, meaning its future value is subject to market fluctuations.
• The deferral of compensation means the director will not realize the immediate value of the vested RSUs in the form of common stock.

Future Outlook

The filing indicates that the 2,975 restricted stock units granted on May 11, 2026, will vest in full on the one-year anniversary of the grant date. Upon vesting, these will also be converted into phantom stock, payable at a future elected date or upon termination of service.

Industry Context

StockSavvy.ai notes that the use of restricted stock units and deferred compensation plans, including phantom stock, is a common practice among publicly traded companies in the chemicals industry to attract, retain, and incentivize key executives and directors.

Related Party Transactions

• The transactions involve director Christopher J. Kuehn and Celanese Corp, his employer and the issuer of the securities, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The transactions reflect standard compensation practices and do not immediately dilute ownership, but the deferral of shares by a director may impact the immediate supply of shares available in the market.
• Employees: The use of equity compensation plans like RSUs and deferred compensation plans is a common incentive structure that can indirectly affect employee morale and retention if perceived as fair and competitive.
• Management: The transactions are part of the compensation structure for directors, aligning their interests with long-term company performance through equity awards.

Next Steps

• The 2,975 restricted stock units granted on May 11, 2026, are expected to vest on May 11, 2027.
• Upon vesting of the new RSUs, they will be converted into phantom stock, with payment to occur at a future elected date or upon termination of service.

Key Dates

Keywords

Celanese Corp, CE, Form 4, Insider Trading, Restricted Stock Units, Phantom Stock, Deferred Compensation, Director Compensation, Equity Awards, SEC Filing